ArticleCurrent protocols2025
Efficient Workflows for Quantifying Tumor Growth on H&E-Stained Digital Sections in Mouse Models of Lung Cancer.
Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Microscopic examination of tissue morphology using hematoxylin and eosin (H&E) staining is a standard practice in histopathology for analyzing tissue specimens. In preclinical models of cancer, H&E-stained tissue sections are routinely used to assess tumor development and progression, including parameters such as tumor number, size, and histopathological features. Recent advances in whole-slide scanning and digital pathology now enable quantitative analysis of high-resolution digital images on a computer, replacing the need to examine physical tissue slides under a microscope. However, quantifying tumors on H&E-stained digital sections remains challenging, highlighting the need for accessible and reproducible methods that can be adapted to diverse tumor models. Here, we present two efficient workflows using QuPath, an open-source software for digital pathology and whole-slide image analysis, to quantify tumor multiplicity (i.e., the number of tumors) and tumor burden (e.g., tumor surface area) based on digitally captured H&E-stained tissue sections. As a proof of concept, we apply these workflows to two distinct lung cancer models: (1) an orthotopic model in which Lewis lung carcinoma (LLC) cells are delivered intranasally or intravenously into syngeneic C57BL/6 mice, resulting in well-separated, easily distinguishable tumors amenable to manual quantification; and (2) a genetically engineered mouse model (GEMM) with lung-specific expression of oncogenic Kras
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.